This portal is a web interface for the Canadian Open Neuroscience Platform (CONP) to facilitate open science in the neuroscience community. CONP simplifies global researcher access and sharing of datasets and tools. The portal internalizes the cycle of a typical research project: starting with data acquisition, followed by processing using already existing/published tools, and ultimately publication of the obtained results including a link to the original dataset. Read more
The PREVENT-AD (Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer's Disease) cohort is composed of cognitively healthy participants over 55 years old, at risk of developing Alzheimer's Disease (AD) as their parents and/or siblings were/are affected by the disease. These ‘at-risk’ participants have been followed for a naturalistic study of the presymptomatic phase of AD since 2011 using multimodal measurements of various disease indicators. One clinical trial intended to test a pharmaco-preventive agent has also been conducted.
The PREVENT-AD dataset is available to researchers around the world with the intention to contribute to the community’s growing understanding of AD pathogenesis.
Authors: StoP-AD Center - Douglas Mental Health University Institute
Learn how the CONP portal works. Read the Portal tutorial or watch the tutorial video below.